COMPANY
Axonova Medical
Funding and NIH signals
- NIH award NIH awarded $903K (SBIR Phase II 5R44NS125892-04, continuation, notice Jun 11, 2026). NIH RePORTER 5R44NS125892-04 (Jun 11, 2026)
Evidence (1 event)
- Jun 11, 2026 · NIH RePORTER 5R44NS125892-04
Organization: AXONOVA MEDICAL, LLC; City/State: PHILADELPHIA, PA; Project number: 5R44NS125892-04; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-06-11; FY total cost (award amount): 902542; Administering IC: National Institute of Neurological Disorders and Stroke; Project title: Development of Tissue Engineered Neuromuscular Interfaces from GalSafe Neurons; Organization type: Domestic For-Profits
- Jun 11, 2026 · NIH RePORTER 5R44NS125892-04
Timeline
- Grant Government grant — SBIR: $902,542 (annual award, as published), announced Jun 11, 2026. Agency: NIH/NINDS. Source: government award database. source ↗
- Grant Government grant — SBIR: $1.1M (annual award, as published), announced Apr 30, 2025. Agency: NIH/NINDS. Source: government award database. source ↗
Funding
NIH awards 6
- NIH award 2R44NS125892-02A1 FY2024: $766,451 awarded for that fiscal year; activity R44 (SBIR); PI KATIYAR, KRITIKA; recipient as written: AXONOVA MEDICAL, LLC, PHILADELPHIA, PA. Development of Tissue Engineered Neur source ↗
- NIH award 5R44NS108869-04 FY2022: $900,965 awarded for that fiscal year; activity R44 (SBIR); PI KATIYAR, KRITIKA; recipient as written: AXONOVA MEDICAL, LLC, PHILADELPHIA, PA. Generation of Tissue Engineered Nerve G source ↗
- NIH award 1R43NS125892-01 FY2022: $250,421 awarded for that fiscal year; activity R43 (SBIR); PI KATIYAR, KRITIKA; recipient as written: AXONOVA MEDICAL, LLC, PHILADELPHIA, PA. Development of Tissue Engineered Neurom source ↗
- NIH award 5R44NS108869-03 FY2021: $934,090 awarded for that fiscal year; activity R44 (SBIR); PI KATIYAR, KRITIKA; recipient as written: AXONOVA MEDICAL, LLC, PHILADELPHIA, PA. Generation of Tissue Engineered Nerve G source ↗
- NIH award 2R44NS108869-02 FY2020: $1,083,394 awarded for that fiscal year; activity R44 (SBIR); PI KATIYAR, KRITIKA; recipient as written: AXONOVA MEDICAL, LLC, PHILADELPHIA, PA. Generation of Tissue Engineered Nerve source ↗
- NIH award 1R43NS108869-01 FY2018: $224,562 awarded for that fiscal year; activity R43 (SBIR); PI LEDEBUR, HARRY; recipient as written: AXONOVA MEDICAL, LLC, PHILADELPHIA, PA. Generation of Tissue Engineered Nerve Gra source ↗